A LOW DISTRIBUTION VOLUME AS A DETERMINANT OF EFFICACY AND SAFETY FOR HISTAMINE (H-1) ANTAGONISTS

被引：30

作者：

TILLEMENT, JP

机构：

[1] Department of Pharmacology, Faculty of Medicine, University of Paris Xii

来源：

ALLERGY | 1995年 / 50卷 / 24期

关键词：

D O I：

10.1111/j.1398-9995.1995.tb04258.x

中图分类号：

R392 [医学免疫学];

学科分类号：

100102 ;

摘要：

引用

页码：12 / 16

页数：5

共 17 条

[1]

BALTES EL, 1987, CETIRIZINE S P NEW E, P45

[2] EVIDENCE FOR ISOXICAM BINDING TO SITE-I AS A PRIMARY SITE AND TO SITE-II AS A SECONDARY SITE OF HUMAN-SERUM ALBUMIN [J].

BREE, F ;

NGUYEN, P ;

ALBENGRES, E ;

URIEN, S ;

RIANT, P ;

WELLING, PG ;

TILLEMENT, JP .

BIOCHEMICAL PHARMACOLOGY, 1989, 38 (05) :753-758

[3]

CHESNE C, 1993, ADV EXP MED BIOL, V331, P113

[4] CARDIOTOXIC EFFECT WITH CONVULSIONS IN TERFENADINE OVERDOSE [J].

DAVIES, AJ ;

HARINDRA, V ;

MCEWAN, A ;

GHOSE, RR .

BRITISH MEDICAL JOURNAL, 1989, 298 (6669) :325-325

[5] HISTAMINE-RECEPTORS - SUBCLASSES AND SPECIFIC LIGANDS [J].

HAAKSMA, EEJ ;

LEURS, R ;

TIMMERMAN, H .

PHARMACOLOGY & THERAPEUTICS, 1990, 47 (01) :73-104

[6]

MATZKE GR, 1987, ANN ALLERGY, V59, P25

[7] INVIVO BINDING-PROPERTIES OF NONSEDATING ANTIHISTAMINES TO CNS HISTAMINE-RECEPTORS [J].

MCQUADE, RD ;

RICHLAN, K ;

DUFFY, RA ;

CHIPKIN, RE ;

BARNETT, A .

DRUG DEVELOPMENT RESEARCH, 1990, 20 (03) :301-306

[8] THE PHARMACOLOGY AND MECHANISMS OF ACTION OF HISTAMINE-H1-ANTAGONISTS [J].

RIMMER, SJ ;

CHURCH, MK .

CLINICAL AND EXPERIMENTAL ALLERGY, 1990, 20 :3-17

[9]

SALE ME, 1993, J ALLERGY CLIN IMMUN, V91, P258

[10]

Simons F E, 1991, Clin Pharmacokinet, V21, P372

← 1 2 →